Multimodality Therapies for Localized Prostate Cancer

By sjmartinez • February 2, 2023

Valle LF, Jiang T, Weiner AB, Reiter RE, Rettig MB, Shen J, Chang AJ, Nickols NG, Steinberg ML, Kishan AU. Multimodality Therapies for Localized Prostate Cancer. Curr Oncol Rep. 2023 Feb 1. doi: 10.1007/s11912-023-01374-9. Epub ahead of print. PMID: 36723856.

Tags: ADT, Genomics, Hematology/Oncology, hormone therapy, Localized prostate cancer, Publications, Radiation, radical prostatectomy, Radiotherapy, SBRT, Surgery, Veterans Administration

Autosomal allelic inactivation at loci with variable replication timing and dosage sensitivity

Heskett MB, Vouzas AE, Johnstone B, Freese KP, Yates PA, Copenhaver PF, Spellman PT, Gilbert DM, Thayer MJ. Autosomal allelic inactivation at loci with variable[...]

A phase Ib/II, open-label, multicenter, randomized umbrella study evaluating the combination of atezolizumab with sacituzumab govitecan in patients with locally advanced or metastatic urothelial carcinoma and previously treated with a platinum-based treatment regimen (MORPHEUS-Urothelial Carcinoma)

Shin SJ, Lee JL, Powles T, Martin-Liberal J, Morales-Barrera R, Drakaki A, Friedlander T, Joly F, Shah SA, Vuky J, Ianculescu I, Michielin F, Gan[...]

The Association Between Healthcare Provider Trust and Healthcare Avoidance: Findings From a HIV Mixed Serostatus Cohort Study

Singleton M, Plankey M, Bowleg L, Brock JB, Haberlen S, Jamieson BD, Kempf MC, Konkle-Parker DJ, Kwait J, Martinson J, Mimiaga MJ, Ramirez CM, Stosor[...]